Benzene is widely used by chemical industries and exposure to benzene has been shown experimentally to be immunotoxic in adult animals. This study addressed whether exposure of fetuses in utero to benzene compromises the development of fetal B lymphopoiesis and whether B-lymphocyte development recovers postnatally. Pregnant BALB/C dams were given intraperitoneal injections of benzene (100 mg/kg, twice daily) from day 12.5 of gestation through day 19.5 of gestation. Phenotypic analysis revealed that fetal liver cell suspensions from embryos exposed in utero contained fewer pre-B cells and B cells than corresponding controls. Fetal liver cell cultures established from these embryos also produced fewer B cells. In contrast, levels of pre-B cells were elevated in the livers of 8-day-old neonates that had been exposed to benzene in utero. Moreover, responsiveness to the B-cell mitogen, LPS, was significantly decreased in spleen cell cultures derived from these neonates. These results indicate that in utero exposure to high concentrations of benzene alters fetal B lymphopoiesis and may compromise immune responsiveness postnatally.
References
1.
1. Pancorbo, O.C., and Varney, T.C. (1986). Fate of synthetic organic chemicals in soil-groundwater systems. Vet. Hum. Toxicol.28, 127–143.
2.
2. Andreoli, A.R., Reynolds, R., Bartilucci, N., and Forgione, R. (1980). Cesspool Cleaner Study Final Report, Suffolk County Department of Health Services, Suffolk County, NY.
3.
3. Burmaster, D.E., and Harris, R.H. (1982). Groundwater contamination: An emerging threat. Technol. Rev.85, 50–62.
4.
4. Lee, S.D., Dourson, M., Murkerjee, D., Stara, J.F., Kawecki, T. (1983). Assessment of benzene health effects in ambient water. Adv. Mod. Environ. Toxicol.4, 91–125.
5.
5. Irons, R.D., Greenlee, W.F., Wierda, D., and Bus, J.S. (1982). Relationship between benzene metabolism and toxicity: A proposed mechanism for the formation of reactive intermediates from polyphenol metabolites. In: Snyder, R., et al. (eds.). Biological Reactive Intermediates.New York: Plenum Press, pp. 229–243.
6.
6. Gofmekler, V.A. (1968). Effect of embryonic development on benzene and formaldehyde inhalation treatment. Hyg. Sanit.33, 327–332.
7.
7. Roberts, D.W., and Chapman, J.R. (1981). Concepts essential to the assessment of toxicity to the developing immune system. In: Kimmel, C.A., and Buelke-Sam, J. (eds.). Developmental Toxicology.New York: Raven Press, pp. 167–190.
8.
8. Schmidt, R.R. (1984). Altered development of immunocompetence following prenatal or combined prenatal-postnatal insult: A timely review. J. Am. Coll. Toxicol.3, 57–72.
9.
9. Solomon, J.B. (1971). Fetal and Neonatal Immunology.New York: North Holland/American Elsevier, pp. 343–361.
10.
10. Gathings, W.E., Kubigawa, H., and Cooper, M.D. (1981). A distinctive pattern of B cell immaturity in perinatal humans. Immunol. Rev.57, 107–126.
11.
11. Heiss, E.R. (1982). Diseases associated with immunosuppression. Environ. Health Perspect.43, 9–12.
12.
12. Vos, J.G. (1977). Immune suppression as related to toxicology. CRC Crit. Rev. Toxicol.5, 67–101.
14. Smialowicz, R.J., Riddle, M.M., Rogers, R.R., Rowe, D.G., Luebke, R.W., Fogelson, L.D., and Copeland, C.B. (1988). Immunologic effects of perinatal exposure of rats to dioctyltin dichloride. J. Toxicol. Environ. Health25, 399–418.
15.
15. Smialowicz, R.J. Riddle, M.M. Rogers, R.R. Luebke, R.W. and Copeland, C.B. (1989). Immunotoxicity of tributlytin oxide in rats exposed as adults or pre-weanlings. Toxicology (in press).
16.
16. Luster, M.I., Mclachlan, J.A., and Clark, C.G. (1979). Effect of in utero exposure to diethylstilbestrol on the immune response in mice. Toxicol. Appl. Pharmacol.47, 279–285.
17.
17. Luster, M.I., Faith, R.E., and Mclachlan, J.A. (1978). Alterations of the antibody response following in utero exposure to diethylstilbestrol. Bull. Environ. Contam. Toxicol.20, 433–437.
18.
18. Kalland, T., Strand, O., and Frosberg, J.G. (1979). Long-term effects of neonatal estrogen treatment on mitogen responsiveness of mouse spleen lymphocytes. J. Natl. Cancer Inst.63, 413–421.
19.
19. Urso, P., and Gengozian, N. (1980). Depressed humoral immunity and increased tumor incidence in mice following in utero exposure to benzo(a)pyrene. J. Toxicol. Environ. Health6, 569–576.
20.
20. Vos, J.G., and Moore, J.A. (1974). Suppression of cellular immunity in rats and mice by maternal treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Int. Arch. Allergy47, 777–794.
21.
21. Faith, R.E., and Moore, J.A. (1977). Impairment of thymus-dependent immune functions by exposure of the developing immune system to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J. Toxicol. Environ. Health3, 451–464.
22.
22. Luster, M.I., Boorman, G.A., Dean, J.H., Luebke, R.W., and Lawson, L. D. (1980). The effect of adult exposure to diethylstilbestrol in the mouse: Alterations in immunologic function. J. Reticuloendothel. Soc.28, 561–569.
23.
23. Smialowicz, R.J., Rogers, R.R., Riddle, M.M., Rowe, D.G., and Leubke, R. W. (1986). Immunological studies in mice following in utero exposure to Ni Cl2. Toxicology28, 293–303.
24.
24. Luebke, R.W., Riddle, M.M., Rogers, R.R., Rowe, D.G., and Garner, R.J. (1986). Immune function in adult C57BL/6J mice following exposure to urethan pre-or postnatally. J. Immunopharm.8, 243–257.
25.
25. Luebke, R.W., Lawson, L.D., Rogers, R.R., Riddle, M.M., and Smialowicz, R.J. (1987). Immune function in mice exposed to the adenosine deaminase inhibitor 2′-deoxycoformycin during immune system development. Immunopharm. Immunotoxicol.9, 149–161.
26.
26. Luebke, R.W., Riddle, M.M., Rogers, R.R., Garner, R.J., Rowe, D.G., and Smialowicz, R.J. (1986). Immune function of young adult mice following in utero exposure of cyclophosphamide. J. Toxicol.18, 25–39.
27.
27. Wierda, D., Irons, R.D., and Greenlee, W.F. (1981). Immunotoxicity in C57BL/6 mice exposed to benzene and Aroclor 1254. Toxicol. Appl. Pharmacol.60, 410–417.
28.
28. Wierda, D., and Irons, R.D. (1982). Hydroquinone and catechol reduce the frequency of progenitor B lymphocytes in mouse spleen and bone marrow. Immunopharmacology4, 41–54.
29.
29. King, A.G. Landreth, K.S. and Wierda, D. (1989). Bone marrow stromal cell regulation of B-lymphopoiesis: Mechanisms of hydroquinone inhibition of pre-B cell maturation. J. Pharmacol. Ther. (in press).
30.
30. King, A.G., Wierda, D., and Landreth, K.S. (1988). Bone marrow stromal cell regulation of B-lymphopoiesis. I. The role of macrophages, IL-1, and IL-4 in Pre-B cell maturation. J. Immunol.141, 2016–2026.
31.
31. Kincade, P.W. (1981). Formation of B lymphocytes in fetal and adult life. Adv. Immunol.31, 177–245.
32.
32. Kincade, P.W., Lee, G., Paige, C.J., Scheid, M.P. (1981). Cellular interactions affecting the maturation of murine B lymphocyte precursors in vitro. J. Immunol.127, 255–260.
33.
33. Paige, C.J. (1983). Surface immunoglobulin negative B cell precursors detected by formation of antibody-secreting colonies in agar. Nature302, 711–713.
34.
34. Paige, C.J., Gisler, R.H., Mckearn, J.P., and Iscove, N.N. (1984). Differentiation of murine B cell precursors in agar culture. Frequency, surface marker analysis and requirements for growth of clonable pre-B cells. Eur. J. Immunol.17, 979–987.
35.
35. Denis, K.A., Treiman, L.J., St. Clair, J.I., and Witte, O.N. (1984). Long-term cultures of murine fetal liver retain very early B lymphoid phenotype. J. Exp. Med.160, 1087–1101.
36.
36. Paige, C.J., Skarvaii, H., and Sauter, H. (1985). Differentiation of murine B cell precursors in agar culture. II. Response of precursor-enriched populations to growth stimuli and demonstration that the clonable pre-B cell assay is limiting for the B cell precursor. J. Immunol.134, 3699–3704.
37.
37. Gisler, R.H., Hollander, G., and Soderberg, A. (1987). Functional maturation of murine B lymphocyte precursors. I. Selection of adherent cell-dependent precursors from bone marrow and fetal liver. J. Immunol.138, 2427–2432.
38.
38. Thomas, D. J., Reasor, M. J., and Wierda, D. (1989). Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. Toxicol. Appl. Pharmacol.97, 440–453.
39.
39. Gaido, K. W., and Wierda, D. (1987). Suppression of bone marrow stromal cell function by benzene and hydroquinone is ameliorated by indomethacin. Toxicol. Appl. Pharmacol.89, 378–390.
40.
40. Gaido, K. W., and Wierda, D. (1985). Modulation of stromal cell function in DBA/2J and B6C3F1 mice exposed to benzene or phenol. Toxicol. Appl. Pharmacol.81, 469–475.
41.
41. Rickert, D. E., Baker, T. S., Bus, J. S., Barrow, C. S., and Irons, R. D. (1979). Benzene disposition in the rat after exposure by inhalation. Toxicol. Appl. Pharmacol.49, 417–423.
42.
42. Melchers, F. (1977). B lymphocyte development in fetal liver. II. Frequencies of precursor B cells during gestation. Env. J. Immunol.7, 482–486.
43.
43. Landreth, K. S., and Kincade, P. W. (1984). Mammalian B lymphocyte precursors. Dev. Comp. Immunol.8, 773–790.
44.
44. Landreth, K. S., Rosse, C., and Clagett, J. (1981). Myelogenous production and maturation of B lymphocytes in the mouse. J. Immunol.127, 2027–2034.
45.
45. Landreth, K. S., Kincade, P. W., Lee, G., and Medlock, E. S. (1983). Phenotypic and functional characterization of murine B lymphocyte precursors isolated from fetal and adult tissues. J. Immunol.131, 572–580.
46.
46. Jyonouchi, H., and Kincade, P. W. (1983). Changes in B lineage cell population in liver and spleen of normal neonatal mice. J. Immunol.130, 1616–1621.
47.
47. Gisler, R. H., Soderberg, A., and Kamber, M. (1987). Functional maturation of murine B lymphocyte precursors. II. Analysis of cells required from the bone marrow microenvironment. J. Immunol.138, 2433–2438.
48.
48. Grossi, C. E., Velardi, A., and Cooper, M. D. (1985). Postnatal liver hemopoiesis in mice: Generation of pre-B cells, granulocytes, and erythrocytes in discrete colonies. J. Immunol.145, 2303–2311.
49.
49. Snyder, R., Lee, E. W., and Kocsis, J. J. (1978). Binding of labeled benzene metabolites to mouse liver and bone marrow. Res. Commun. Chem. Pathol. Pharmacol.20, 191–194.
50.
50. Andrews, L. S., Lee, E. W., Witmar, C. M., Kocsis, J. J., and Snyder, R. (1977). Effects of toluene on the metabolism, disposition and hemopoietic toxicity of [3H] benzene. Biochem. Pharmacol.26, 293–300.
51.
51. Greenlee, W., Gross, E. A., and Irons, R. D. (1981). Relationship between benzene toxicity and the disposition of 14C-labelled benzene metabolites in the rat. Chem.-Biol. Interact.33, 285–299.
52.
52. Ghantous, H., and Danielsson, B. R. G. (1986). Placental transfer and distribution of toluene, xylene and benzene, and their metabolites during gestation in mice. Biol. Res. Preg.7, 98–105.
53.
53. Longacre, S. L., Kocsis, J. J., Witmer, C. M., Lee, E. W., Sammett, D., and Snyder, R. (1981). Toxicological and biochemical effects of repeated administration of benzene in mice. J. Toxicol. Environ. Health7, 223–237.
54.
54. Andrew, T. A., and Owen, J. J. T. (1978). Studies on the earliest sites of B cell differentiation in the mouse embryo. Dev. Comp. Immunol.2, 339–346.
55.
55. Owen, J. J. T., Cooper, M. D., and Raff, M. C. (1974). In vitro generation of B lymphocytes in mouse fetal liver, a mammalian bursal equivalent. Nature249, 361–363.
56.
56. Raff, M. C., Megson, M., Owen, J. J. T., and Cooper, M. D. (1976). Early production of intracellular Ig M by B-lymphocyte precursors in mouse. Nature259, 224–226.
